Randall K. Johnson

No más puestos en curso

77 años

Health Technology

Perfil

Randall K.
Johnson worked as an Independent Director at Callisto Pharmaceuticals, Inc. from 2005 to 2013.
Prior to that, he was the Group Director of the Oncology Research Department at GSK Plc from 1982 to 2002.
He also held the same position at Smithkline Beecham Pharmaceuticals (Canada).

Antiguos cargos conocidos de Randall K. Johnson.

Empresas	Cargo	Fin
Callisto Pharmaceuticals, Inc. Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.	Director/Miembro de la Junta	22/01/2013
GSK PLC	Corporate Officer/Principal	01/02/2002
Smithkline Beecham Pharmaceuticals (Canada)	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Randall K. Johnson.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Randall K. Johnson.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
GSK PLC	Health Technology

Empresas privadas	2
Callisto Pharmaceuticals, Inc. Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.	Health Technology
Smithkline Beecham Pharmaceuticals (Canada)